Medical Xpress October 8, 2024
Karolinska Institutet

Prostate cancer is the most common cancer among men in Sweden, with about 10,000 new cases diagnosed annually. Despite advancements in diagnostics and treatments, managing prostate cancer remains challenging due to its often silent progression and the complexities surrounding early detection.

The Prostate-Specific Antigen (PSA) test, while widely used, has limitations in distinguishing between aggressive and indolent cancers and benign conditions, leading to potential overdiagnosis and overtreatment.

In his thesis, Lars Björnebo, MD and Ph.D. student at the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, investigated and compared new tools for detection, such as MRI-based diagnostics and the Stockholm3 test, potentially offering hope for more accurate diagnoses. However, ensuring access to these innovations and balancing timely intervention...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Interview / Q&A, Provider, Trends
From 2025 Market Overview: How the tech market for older adults evolves
What Would The Ideal Hospital Look Like? - 2
AAFP’s prescription for primary care success in 2025
How AI is transforming medicine faster than ever before
How diversifying the medical profession leads to better health outcomes for all

Share This Article